MarketCap
Stryker Corporation SYK
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
382 M |
Market Cap[1] |
$ 124 B |
EBITDA (LTM) |
$ 6.46 B |
P/E (LTM) |
137.162896 |
P/S (LTM) |
16.156225 |
EPS (LTM) |
2.21 |
Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.
Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.
The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.
One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.
Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
$ 5.53 | 0.73 % | $ 3.73 M | Nasdaq Capital Market | USA |
 |
Apyx Medical Corporation
APYX
|
$ 2.95 | 0.34 % | $ 121 M | Nasdaq Global Select Market | USA |
 |
Establishment Labs Holdings
ESTA
|
$ 67.19 | -1.94 % | $ 1.99 B | Nasdaq Capital Market |  Costa-rica |
 |
Delcath Systems
DCTH
|
$ 20.08 | -0.96 % | $ 719 M | Nasdaq Capital Market | USA |
 |
Electromed
ELMD
|
$ 27.2 | 1.29 % | $ 225 M | NYSE American | USA |
 |
Inogen
INGN
|
$ 6.02 | -1.64 % | $ 160 M | Nasdaq Global Select Market,SPB | USA |
 |
Globus Medical
GMED
|
$ 75.35 | -1.34 % | $ 10.2 B | NYSE,SPB | USA |
 |
IRadimed Corporation
IRMD
|
$ 86.87 | -0.08 % | $ 1.11 B | Nasdaq Global Select Market | USA |
 |
ClearPoint Neuro
CLPT
|
$ 8.79 | -4.2 % | $ 249 M | Nasdaq Capital Market | USA |
 |
Accuray Incorporated
ARAY
|
$ 3.17 | -17.02 % | $ 389 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 50.89 | 0.49 % | $ 2.34 B | Nasdaq Capital Market,SPB | USA |
 |
IRIDEX Corporation
IRIX
|
$ 0.7 | -0.41 % | $ 11.9 M | Nasdaq Global Select Market | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 5.81 | -0.34 % | $ 362 M | Nasdaq Capital Market | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
$ 14.54 | 1.18 % | $ 1.11 B | Nasdaq Global Select Market,SPB | USA |
 |
Bruker Corporation
BRKR
|
$ 62.25 | -5.4 % | $ 9.45 B | Nasdaq Global Select Market,SPB | USA |
 |
LivaNova PLC
LIVN
|
$ 91.39 | -1.32 % | $ 4.99 B | Nasdaq Global Select Market |  Britain |
 |
LENSAR
LNSR
|
$ 4.97 | -8.97 % | $ 59.4 M | Nasdaq Capital Market | USA |
 |
Orthofix Medical
OFIX
|
$ 7.12 | -9.94 % | $ 282 M | Nasdaq Global Select Market,SPB |  Curacao |
 |
Pulmonx Corporation
LUNG
|
$ 2.81 | 0.18 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
InspireMD
NSPR
|
$ 0.78 | 9.49 % | $ 50.2 M | NYSE American |  Israel |
 |
InMode Ltd.
INMD
|
$ 13.26 | -1.89 % | $ 857 M | Nasdaq Global Select Market,SPB | Israel |
 |
OrthoPediatrics Corp.
KIDS
|
$ 33.43 | -1.65 % | $ 784 M | Nasdaq Global Select Market,SPB | USA |
 |
Outset Medical
OM
|
$ 4.22 | 2.43 % | $ 64.2 M | Nasdaq Global Select Market | USA |
 |
PAVmed
PAVM
|
$ 1.64 | 0.31 % | $ 1.1 M | Nasdaq Capital Market | USA |
 |
Sintx Technologies
SINT
|
$ 1.56 | 4.36 % | $ 4.33 M | Nasdaq Capital Market | USA |
 |
AVITA Medical
RCEL
|
$ 17.62 | 2.92 % | $ 491 M | Nasdaq Global Select Market |  Australia |
 |
Tandem Diabetes Care
TNDM
|
$ 18.7 | 2.92 % | $ 1.27 B | Nasdaq Global Market,SPB | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | Israel |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 7.72 | 4.97 % | $ 1.04 B | Nasdaq Capital Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
Inspire Medical Systems
INSP
|
$ 62.36 | -3.06 % | $ 1.83 B | NYSE,SPB | USA |
 |
Integer Holdings Corporation
ITGR
|
$ 126.66 | 0.08 % | $ 4.4 B | NYSE,SPB | USA |
 |
Avanos Medical
AVNS
|
$ 24.99 | - | $ 1.16 B | NYSE,SPB | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Helius Medical Technologies
HSDT
|
$ 1.83 | -4.69 % | $ 40.3 M | Nasdaq Capital Market | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
FONAR Corporation
FONR
|
- | - | $ 140 M | Nasdaq Capital Market | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | USA |
 |
Ra Medical Systems
RMED
|
- | 10.0 % | $ 610 K | NYSE American | USA |
 |
ReWalk Robotics Ltd.
RWLK
|
- | 7.07 % | $ 66.1 M | Nasdaq Global Select Market | Israel |
 |
STRATA Skin Sciences
SSKN
|
- | - | $ 6.6 M | Nasdaq Global Select Market | USA |
 |
Abbott Laboratories
ABT
|
$ 110.59 | 0.07 % | $ 193 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.